All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
The land grab for assets continued at a torrid pace in the second quarter as pharma and biotech companies opened their bulging wallets to help strengthen pipelines and position themselves in future emerging technologies.